4.7 Article

Inhibitory effect on the proliferation of human heptoma induced by cell-permeable manganese superoxide dismutase

期刊

BIOMEDICINE & PHARMACOTHERAPY
卷 83, 期 -, 页码 1379-1386

出版社

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.biopha.2016.08.054

关键词

TAT-MnSOD; Redox homeostasis; ROS; P-survivin (Thr34)

资金

  1. National Natural Science Foundation [30873190, 31300660]
  2. Science and technology innovation action plan of Shanghai [14431904300]
  3. Shanghai Pujiang Program [13PJD012]
  4. foundation for young teacher from Education Ministry of China [20120074120027]
  5. National Science Research Project Significant New Drugs Created of Eleventh Five-year Plan [2009ZX09103-693]

向作者/读者索取更多资源

Mitochondrial antioxidant manganese superoxide dismutase (MnSOD) belongs to a group of genes whose expression is generally decreased significantly in patients with hepatoma. The proliferation of cancer cells with low expression of MnSOD exhibit high sensitivity to the elevated expression of MnSOD. However, due to the lack of ability to penetrate the cell membrane, the direct use and study of SOD for cancer treatment are largely hampered. In this work, cell penetrating peptide TAT was fused to the Nterminus of MnSOD to facilitate the penetration of MnSOD through cell membranes. Results showed that TAT-MnSOD wt treatment induced evident inhibitory effect on the proliferation of heptoma, with minimal effect on normal cells. It was further demonstrated that both the penetration of cells and enzymatic activity of MnSOD are essential to its inhibitory function, because only TAT-MnSOD wt, not inactive TAT-MnSOD mutant or MnSOD could successfully inhibit cell proliferation and reduce the intracelluar reactive oxygen species (ROS). In addition, the lower oxidative stress delayed the cell cycle at G2/M and significantly slowed HepG2 cell growth in association with the dephosphorylation of survivin. Our results help in understanding the regulatory effects of MnSOD on cell viability and redox homestasis of heptoma and promise potential applications of TAT-MnSOD wt for clinical cancer therapy. (C) 2016 Published by Elsevier Masson SAS.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据